Aristeia Capital LLC Biomarin Pharmaceutical Inc Transaction History

Aristeia Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $884,988 - $1.2 Million	-12,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $80,880 - $102,132	-1,200 Reduced 8.82%	12,400 $836,000
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $2.02 Million - $2.37 Million	-25,200 Reduced 64.95%	13,600 $1.17 Million
Q1 2019 May 16, 2019	BUY	$84.2 - $98.62 $3.27 Million - $3.83 Million	38,800 New	38,800 $3.45 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Aristeia Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Aristeia Capital LLC with notifications on news.